Cambridge Investment Research Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.23M Sell
130,636
-6,946
-5% -$322K 0.01% 902
2026
Q1
$6.03M Buy
137,582
+41,892
+44% +$1.91M 0.02% 867
2025
Q4
$4.24M Sell
95,690
-1,450
-1% -$62.5K 0.01% 1015
2025
Q3
$4.1M Buy
97,140
+13,739
+16% +$554K 0.01% 1025
2025
Q2
$3.06M Buy
83,401
+9,626
+13% +$357K 0.01% 1135
2025
Q1
$2.81M Buy
73,775
+17,209
+30% +$640K 0.01% 1143
2024
Q4
$2.14M Buy
56,566
+1,470
+3% +$58.7K 0.01% 1311
2024
Q3
$2.24M Buy
55,096
+5,824
+12% +$220K 0.01% 1267
2024
Q2
$1.69M Sell
49,272
-964
-2% -$30.4K 0.01% 1407
2024
Q1
$1.59M Sell
50,236
-5,343
-10% -$162K 0.01% 1407
2023
Q4
$1.7M Sell
55,579
-7,380
-12% -$237K 0.01% 1309
2023
Q3
$2.09M Sell
62,959
-4,105
-6% -$131K 0.01% 1107
2023
Q2
$2.06M Buy
67,064
+7,621
+13% +$220K 0.01% 1154
2023
Q1
$1.63M Buy
59,443
+7,175
+14% +$200K 0.01% 1250
2022
Q4
$1.46M Buy
52,268
+286
+0.6% +$8.63K 0.01% 1274
2022
Q3
$1.53M Buy
51,982
+628
+1% +$19.7K 0.01% 1197
2022
Q2
$1.45M Buy
51,354
+3,659
+8% +$104K 0.01% 1217
2022
Q1
$1.49M Sell
47,695
-2,967
-6% -$87.5K 0.01% 1317
2021
Q4
$1.5M Sell
50,662
-5,977
-11% -$175K 0.01% 1321
2021
Q3
$1.7M Sell
56,639
-12,319
-18% -$424K 0.01% 1196
2021
Q2
$2.5M Buy
68,958
+8,266
+14% +$307K 0.01% 986
2021
Q1
$2.22M Buy
60,692
+798
+1% +$29.4K 0.01% 952
2020
Q4
$2.17M Sell
59,894
-8,951
-13% -$303K 0.01% 882
2020
Q3
$2.06M Buy
68,845
+1,135
+2% +$35.4K 0.01% 793
2020
Q2
$2.01M Buy
67,710
+5,038
+8% +$149K 0.02% 772
2020
Q1
$1.66M Sell
62,672
-10,322
-14% -$392K 0.02% 746
2019
Q4
$3.09M Buy
72,994
+2,729
+4% +$115K 0.02% 625
2019
Q3
$2.94M Buy
70,265
+1,285
+2% +$50K 0.03% 610
2019
Q2
$2.54M Sell
68,980
-5,006
-7% -$183K 0.02% 632
2019
Q1
$2.82M Buy
73,986
+13,674
+23% +$507K 0.03% 583
2018
Q4
$2.12M Sell
60,312
-1,923
-3% -$66.7K 0.02% 619
2018
Q3
$2.04M Sell
62,235
-2,742
-4% -$87.3K 0.02% 684
2018
Q2
$2.01M Sell
64,977
-681
-1% -$19.5K 0.02% 650
2018
Q1
$1.77M Sell
65,658
-31
-0% -$827 0.02% 665
2017
Q4
$1.81M Buy
65,689
+13,061
+25% +$377K 0.02% 628
2017
Q3
$1.68M Buy
52,628
+4,226
+9% +$135K 0.02% 594
2017
Q2
$1.6M Buy
48,402
+8,038
+20% +$266K 0.02% 602
2017
Q1
$1.33M Buy
40,364
+9,179
+29% +$295K 0.02% 611
2016
Q4
$975K Buy
31,185
+78
+0.3% +$2.41K 0.02% 688
2016
Q3
$1.1M Buy
31,107
+4,877
+19% +$173K 0.02% 633
2016
Q2
$891K Sell
26,230
-2,143
-8% -$71.5K 0.02% 660
2016
Q1
$1M Buy
28,373
+508
+2% +$16.6K 0.02% 576
2015
Q4
$975K Buy
27,865
+4,166
+18% +$144K 0.02% 554
2015
Q3
$833K Buy
23,699
+2,307
+11% +$81K 0.02% 540
2015
Q2
$734K Buy
21,392
+716
+3% +$26.3K 0.02% 638
2015
Q1
$839K Sell
20,676
-2,187
-10% -$90.5K 0.02% 568
2014
Q4
$893K Buy
22,863
+5,649
+33% +$214K 0.03% 531
2014
Q3
$589K Buy
17,214
+2,138
+14% +$78.7K 0.02% 732
2014
Q2
$556K Buy
15,076
+2,026
+16% +$72.3K 0.02% 699
2014
Q1
$437K Sell
13,050
-96
-0.7% -$3.06K 0.02% 777
2013
Q4
$392K Buy
13,146
+636
+5% +$20.2K 0.02% 758
2013
Q3
$374K Buy
+12,510
New +$381K 0.02% 744

Other funds holding OHI

Cambridge Investment Research Advisors's OHI Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Omega Healthcare (OHI) stake by 5% in Q2 2026, selling an estimated $322K and leaving 130,636 shares worth $6.23M. The position accounts for 0.01% of the portfolio, ranked #902.

Cambridge Investment Research Advisors first reported a position in OHI in Q3 2013 and has held it in 52 quarters since. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Cambridge Investment Research Advisors held 130,636 shares of Omega Healthcare worth $6.23M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 6,946 Omega Healthcare shares in Q2 2026, an estimated $322K.
  • Omega Healthcare made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #902 holding.
  • Cambridge Investment Research Advisors first reported a position in Omega Healthcare in Q3 2013 and has held it in 52 quarters since.
  • 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.